<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> SJMN91-06327093 </DOCNO><ACCESS> 06327093 </ACCESS><DESCRIPT>  MEDICAL; GENETIC; TECHNOLOGY; COMPANY; EARNINGS; DECREASE  </DESCRIPT><LEADPARA>  Calgene Inc., a biotechnology company based in Davis, has announced a net lossof $4.8 million, or 37 cents a share, on revenues of $4.3 million for itsfirst quarter ended Sept. 30.;   This compares with a net loss of $3.6million, or 34 cents a share, during the same period last year when the firmhad revenues of $3.9 million.  </LEADPARA><SECTION>  Business  </SECTION><HEADLINE>  CALGENE REPORTS A LOSS  </HEADLINE><TEXT>     The recent loss includes a one-time charge of $2 million, or 13 cents ashare, for the purchase of the exclusive North American fresh market tomatorights to the FLAVR SAVR gene from Campbell Soup Co.;   Gross profit from netproduct sales for the current period was $721,000, an increase of $486,000over the prior year.  </TEXT><BYLINE>  McClatchy News Service  </BYLINE><COUNTRY>  USA  </COUNTRY><CITY>  Sacramento  </CITY><EDITION>  Home  </EDITION><CODE>  SJ  </CODE><NAME>  San Jose Mercury News  </NAME><PUBDATE>   911122  </PUBDATE> <DAY>  Friday  </DAY><MONTH>  November  </MONTH><PG.COL>  6F  </PG.COL><PUBYEAR>  1991  </PUBYEAR><REGION>  WEST  </REGION><STATE>  CA  </STATE><WORD.CT>  118  </WORD.CT><DATELINE>  Friday, November 22, 199100327093,SJ1  </DATELINE><COPYRGHT>  Copyright 1991, San Jose Mercury News  </COPYRGHT><LIMLEN>  1  </LIMLEN><LANGUAGE>  ENG  </LANGUAGE></DOC>